North South Ventures is a cross-border venture capital firm founded in 2021 and headquartered in San Francisco, California. The firm specializes in early-stage investments within the healthcare sector, focusing on biotechnology, medical devices, and digital health/AI. Operating in prominent academic medical superclusters, including Stanford/UCSF and the University of Toronto, North South Ventures leverages its strategic locations to identify and support innovative healthcare startups.

Since its inception, the firm has invested in over 350 medical portfolio companies, contributing to more than 40 FDA approvals. With cumulative funding exceeding $4 billion, North South Ventures has also facilitated three multi-billion dollar initial public offerings.